UK's role in global health research innovation

Jenevieve Mannell, Ibrahim Abubakar, Andrew Bastawrous, David Osrin, Preeti Patel, Peter Piot, Martin Prince, Jim Smith, Robert J. Wilkinson, Richard Horton

Research output: Contribution to journalComment/debate

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)721-723
Number of pages3
JournalThe Lancet
Volume391
Issue number10122
DOIs
Publication statusPublished - 24 Feb 2018
Externally publishedYes

Bibliographical note

Funding Information:
AB is CEO and receives a salary from Peek Vision Ltd, a wholly owned trading subsidiary of The Peek Vision Foundation. JS is an employee of the Wellcome Trust and has a laboratory in the Francis Crick Institute supported by core funding from the Medical Research Council, Cancer Research UK, and Wellcome Trust. RJW reports grants from Wellcome Trust, Research Councils UK, National Institutes of Health, European Commission, European & Developing Countries Clinical Trials Partnership, South African Medical Research Council, Foundation for the National Institutes of Health, and National Research Foundation of South Africa. We declare no other competing interests. This Comment was written by participants in an event on The UK Contribution to Innovation in Global Health held at the Francis Crick Institute, London, UK, on Dec 4, 2017. The event was organised by University College London, Imperial College London, London School of Hygiene & Tropical Medicine, King's College London, and the Francis Crick Institute with funding from the Wellcome Trust and Medical Research Council.

Funding Information:
UK funders are trying to address these problems. Examples include the £1·5 billion Global Challenges Research Fund for the development needs of ODA-recipient countries; the Wellcome Developing Excellence in Leadership, Training and Science Initiative for research and training programmes led by African scholars; and the £735 million Newton Fund , which includes partner countries in decision making and financial contributions. These innovative models need to be studied. Major funding schemes from resource-rich settings should be designed to encourage and leverage local LMIC co-funding for better ownership and sustainability of research programmes.

Cite this